GW&K Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50.1M Buy
472,561
+2,015
+0.4% +$214K 0.45% 75
2025
Q1
$58.4M Buy
470,546
+6,543
+1% +$812K 0.54% 52
2024
Q4
$57.1M Buy
464,003
+97,589
+27% +$12M 0.49% 67
2024
Q3
$40.8M Sell
366,414
-2,932
-0.8% -$327K 0.35% 113
2024
Q2
$39.4M Buy
369,346
+5,600
+2% +$598K 0.36% 108
2024
Q1
$43.8M Sell
363,746
-3,119
-0.9% -$376K 0.39% 108
2023
Q4
$45.1M Sell
366,865
-19,980
-5% -$2.46M 0.42% 90
2023
Q3
$50.1M Sell
386,845
-15,479
-4% -$2M 0.5% 74
2023
Q2
$49.9M Sell
402,324
-9,802
-2% -$1.22M 0.47% 81
2023
Q1
$60.3M Buy
412,126
+71,214
+21% +$10.4M 0.58% 54
2022
Q4
$54.3M Sell
340,912
-9,019
-3% -$1.44M 0.55% 61
2022
Q3
$46.6M Sell
349,931
-27,106
-7% -$3.61M 0.51% 68
2022
Q2
$58.8M Sell
377,037
-42,705
-10% -$6.66M 0.63% 40
2022
Q1
$65.3M Buy
419,742
+19,649
+5% +$3.06M 0.58% 48
2021
Q4
$51M Buy
400,093
+134,029
+50% +$17.1M 0.43% 95
2021
Q3
$34.6M Sell
266,064
-3,345
-1% -$436K 0.31% 144
2021
Q2
$47.9M Buy
269,409
+3,962
+1% +$704K 0.42% 97
2021
Q1
$43.6M Buy
265,447
+29,558
+13% +$4.86M 0.4% 103
2020
Q4
$38.9M Buy
235,889
+14
+0% +$2.31K 0.41% 98
2020
Q3
$33.6M Buy
235,875
+42,982
+22% +$6.13M 0.44% 90
2020
Q2
$21.3M Buy
192,893
+1,375
+0.7% +$152K 0.3% 149
2020
Q1
$19.1M Buy
191,518
+9,618
+5% +$959K 0.34% 124
2019
Q4
$27.2M Sell
181,900
-5,788
-3% -$864K 0.36% 123
2019
Q3
$24.1M Buy
187,688
+53,512
+40% +$6.86M 0.34% 134
2019
Q2
$19.1M Buy
134,176
+1,188
+0.9% +$169K 0.29% 156
2019
Q1
$19M Buy
132,988
+46,583
+54% +$6.66M 0.31% 150
2018
Q4
$10.7M Buy
+86,405
New +$10.7M 0.21% 172